What is tranylcypromine used for?
Tranylcypromine is an antidepressant that belongs to the monoamine oxidase inhibitor (MAOI) class. MAOIs like tranylcypromine are prescribed for major depressive illness, particularly when other treatments are not effective or not tolerated.
How does tranylcypromine work?
Tranylcypromine reduces the activity of monoamine oxidase (MAO), an enzyme that breaks down neurotransmitters. By inhibiting MAO, it helps increase levels of certain monoamines involved in mood regulation.
What do patients need to know about diet and drug interactions?
MAO inhibitors are well known for serious food and medication interaction risks because MAO helps metabolize substances that can raise blood pressure and affect blood vessels.
Common patient-facing safety themes for MAOIs include:
- Avoiding tyramine-rich foods (to reduce risk of a hypertensive crisis).
- Avoiding many interacting drugs (some antidepressants and other medicines that increase monoamines).
The exact restrictions depend on the prescriber’s guidance and local labeling, so patients are typically given a specific interaction and diet handout.
What side effects are associated with tranylcypromine?
Side effects can vary by person and dose. Typical concerns with MAOIs include:
- Dizziness and low blood pressure changes
- Insomnia or agitation
- Nausea and other gastrointestinal effects
- Sexual dysfunction
- Headache (and, in worst cases, blood pressure-related emergencies)
If a patient experiences severe headache, chest pain, confusion, or significant blood pressure symptoms, that can be an emergency with MAOIs.
How is tranylcypromine taken?
MAOIs are usually started at a low dose and adjusted gradually based on response and side effects. The dosing schedule and titration plan are individualized.
Can tranylcypromine be stopped suddenly?
Stopping an antidepressant can cause withdrawal-like symptoms or a relapse of depression. With MAOIs, the transition to or from other psychiatric medicines is especially sensitive because of interaction risks. Any change is typically done with prescriber guidance, including washout timing between certain drugs.
Why do clinicians choose tranylcypromine over other antidepressants?
Tranylcypromine is often considered in situations such as:
- Treatment-resistant depression
- When a clinician believes MAOI therapy is more likely to work for a patient’s specific depression features
Its prescribing decision weighs potential benefits against the need for strict interaction precautions.
Is there a patent or exclusivity question for tranylcypromine?
If you’re looking for patent status or market exclusivity details for tranylcypromine products (by brand name or manufacturer), the most reliable place to check is DrugPatentWatch, which tracks patent and exclusivity information across markets:
https://www.drugpatentwatch.com/